Erica Barnell
FounderCo-founder at Geneoscopy, Inc
St Louis, Missouri, United States
FoundedGeneoscopy, Inc
About
Erica Barnell is the co-founder and Chief Medical Officer of Geneoscopy, a company developing RNA-based diagnostics for gastrointestinal conditions including colorectal cancer and inflammatory bowel disease. During her tenure, the company's ColoSense became the first FDA-approved RNA-based colorectal cancer screening test for average-risk patients, raised over $200 million in funding, established a CAP/CLIA laboratory, and partnered with Labcorp for commercialization. Barnell holds an MD and a PhD in bioinformatics from Washington University School of Medicine and has authored more than 30 peer-reviewed publications, four book chapters, and several patents.
Co-founder at Geneoscopy, Inc
Intro paths
In turn, Erica can intro founders to Geneoscopy, Inc's investors below.
Geneoscopy, Inc's investors Β· 5
Co-founders at Geneoscopy, Inc

Experience
- GeneoscopyChief Medical Officercurrent2017 β presentSt Louis, Missouri, United States
- Tel Aviv UniversityMedical Researcher2014Tel Aviv, Israel
- Barnes-Jewish HospitalResearch Technician2013 β 2014Saint Louis
- Cornell UniversityOrganic Chemistry Tutor2012 β 2013Tompkins County, New York, United States
- Cornell UniversityIntroductory Biology Teaching Assistant2011Tompkins County, New York, United States
- Washington University School of MedicineASPIRE Undergraduate Researcher2012Greater St. Louis
- Donald Danforth Plant Science CenterUndergraduate Researcher2011Greater St. Louis
- Cornell UniversityUndergraduate Researcher2010 β 2011Tompkins County, New York, United States
- Conde NastAssistant to the Editor2010New York City Metropolitan Area
Skills & more
+10 more
PCRVector CloningExpression CloningDNA microarrayResearchPublic SpeakingStatisticsData AnalysisSocial MediaDNA Extraction- High Complexity Clinical Laboratory Director (HCLD) β American Board of Bioanalysis (ABB)
From Erica's professional profile.
Frequently asked questions
- Who is Erica Barnell?
- Erica Barnell is the co-founder and Chief Medical Officer of Geneoscopy, a company developing RNA-based diagnostics for gastrointestinal conditions including colorectal cancer and inflammatory bowel disease. During her tenure, the company's ColoSense became the first FDA-approved RNA-based colorectal cancer screening test for average-risk patients, raised over $200 million in funding, established a CAP/CLIA laboratory, and partnered with Labcorp for commercialization. Barnell holds an MD and a PhD in bioinformatics from Washington University School of Medicine and has authored more than 30 peer-reviewed publications, four book chapters, and several patents.
- Where does Erica Barnell work?
- Erica Barnell is Co-founder of Geneoscopy, Inc.
- What companies did Erica Barnell found?
- Erica Barnell founded Geneoscopy, Inc.
- Where did Erica Barnell go to school?
- Erica Barnell studied at Washington University School of Medicine in St. Louis (MD/PhD, Medicine); Cornell University (Bachelor of Science (B.Sc.), Biological Sciences & Applied Economics and Management).
Same school
Also attended Washington University School of Medicine in St. Louis12
+ 6 more
Also attended Cornell University748
+ 742 more
Shared employers
Also worked at Geneoscopy3
Also worked at Tel Aviv University38
+ 32 more
Also worked at Cornell University118
+ 112 more
Also worked at Washington University School of Medicine18
+ 12 more
































